Liver involvement is a common feature of leptospirosis. It is variable from mild to severe hepatic dysfunction. Objective: to analyze liver involvement and to assess its prognostic value in leptospirosis. Materials and methods: We performed analysis of 100 consecutive leptospirosis cases treated in Clinic of Infectious Diseases at University Hospital – Pleven (1976-2015)(90 male, mean age 37±18 years, lethal outcome in 13%), followed by comparative analysis of group with liver involvement (n1=71) versus group without liver involvement (n2=29). Results: Fever (100%), hepatomegaly (92%), myalgia (86%), vomiting (84%), splenomegaly (74%), oliguria (69%), jaundice (63%), hypotension (49%), abdominal pain (41%), and hemorrhagic diathesis (37%) were the characteristic manifestations. Headache, myalgia, abdominal pain, oliguria, hemorrhagic diathesis, myocarditis, acute respiratory failure and pancreatitis had had a significantly higher prevalence in the group with liver involvement. Increased levels of total bilirubin (mean 157.8±71.5 µmol/L) with prevalent direct fraction, ASAT (mean 112±18 IU/L), ALAT (mean 96±78 IU/L), hypoproteinemia and hypoalbuminemia were the main laboratory parameters that expressed hepatic dysfunction. Conclusion: The most affected liver functions are bilirubin metabolism and protein synthesis. Liver involvement in leptospirosis is important factor for severity, in combination with acute renal failure has severe course and requires early diagnosis and prompt intensive treatment.
Galya Ivanova Gancheva,
Liver Involvement in Leptospirosis, International Journal of Infectious Diseases and Therapy.
Vol. 1, No. 1,
2016, pp. 6-12.
P. Levett, “Leptospirosis,” Clin Microbiol Rev, 2001, vol. 14, pp. 296–326.
A. Spichler, P. Vilaça, D. Athanazio, J. Albuquerque, M. Buzzar, B. Castro, A. Seguro, and J. Vinetz, “Predictors of lethality in severe leptospirosis in urban Brazil,” Am. J. Trop. Med. Hyg., 2008, vol. 79, pp. 911–914.
R. Lozano, M. Naghavi, K. Foreman, S. Lim, K. Shibuya, V. Aboyans V, et al, “Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010,” Lancet, 2012, vol. 380, pp. 2095–128.
F. Costa, J. Hagan, J. Calcagno, M. Kane, P. Torgerson, M. Martinez-Silveira, C. Stein, B. Abela-Ridder, and A. Ko, “Global morbidity and mortality of leptospirosis: A systematic review,” PLoS Negl. Trop. Dis., 2015, vol. 9: e0003898.
P. Torgerson, J. Hagan, F. Costa, J. Calcagno, M. Kane, M. Martinez-Silveira, M. Goris, C. Stein, A. Ko, and B. Abela-Ridder, “Global burden of leptospirosis: estimated in terms of disability adjusted life years,” Plos Negl. Trop. Dis., 2015, vol. 9: e0004122.
K. Evangelista, and J. Coburn, “Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses,” Future Microbiol., 2010, vol. 5 (9), pp. 1413–1425.
G. Gancheva, “Complex studies upon leptospirosis [dissertation],” Pleven: University of Pleven, 2006, pp. 68-71. Bulgarian
E. Tasseva, I. Christova, T. Gladnishka, I. Trifonova, and V. Ivanova, “Leptospirosis in humans in Bulgaria – a new challenge for medicine or problem solved. Retrospective analysis of infection for 2010–2011,” Sci Infectol./Parasitol., 2012, vol. 1, pp. 22–29.
S. Shivakumar, and P. Shareek, “Diagnosis of leptospirosis using modified Faine’s criteria,” J. Assoc. Physicians India, 2004, vol. 52, pp. 678–679.
P. Vijayachari, A. P. Sugunan, and A. N. Shriram, “Leptospirosis: an emerging global public health problem,” J. Biosci., 2008, vol. 33(4), pp. 557–569.
M. DebMandal, S. Mandal, and N. Pal, “Is jaundice a prognosis of leptospirosis?” Asian Pacif. J. of Trop. Dis., 2011, pp. 279–281.
C. Herrmann-Storck, M. Louis, T. Foucand, I. Lamaury, J. Deloumeaux, G. Baranton, S. Simonetti, N. Sertour, M. Nicolas, J. Salin, and M. Cornet, “Severe Leptospirosis in Hospitalized Patients, Guadeloupe,” Emerg. Infect. Dis., 2010, vol. 16(2), pp. 331–334.
B. Ananthi, L. Sriram, and G. Sumathi, “Evaluation of different laboratory parameters in the diagnosis of leptospirosis,” JEMDS, 2013, vol. 24(8): pp. 9395–9403.
P. Tailor, M. Kapadia, K. Modi, and K. Soni, “Study of Routine Biochemistry Analytes in Leptospirosis for Evaluating Organ and System Specific Involvement,” NJIRM, 2014, vol. 5(4), pp. 44–46.
E. Daher, R. Lima, G. Silva Jr, E. Silva, N. Karbage, R. Kataoka, P. Carvalho Jr, M. Magalhães, R. Mota, and A. Libório, “Clinical presentation of leptospirosis: a retrospective study of 201 patients in a metropolitan city of Brazil,” Braz. J. Infect. Dis., 2010, vol. 14(1), pp. 3–10.
S. Rajapakse, C. Rodrigo, and R. Haniffa, “Developing a clinically relevant classification to predict mortality in severe leptospirosis,” J. Emerg. Trauma Shock [serial online], 2010 [cited 2015 Feb 6], vol. 3, pp. 213–219.
C. Leonidas, G. Kalambokis, and E. Tsianos, “Weil’s Disease in a Patient with Chronic Viral Hepatitis and History of Alcohol Abuse,” Inter. Med., 2008, vol. 47, pp. 933–937.
C. Yang, M. Wu, and M. Pan, “Leptospirosis renal disease,” Nephrol. Dial. Transplant., 2001, vol. 16 (Suppl 5), S73 – S77.
A. Covic, D. Goldsmith, P. Gusbeth-Tatomir, A. Seica, and M. Covic, “A retrospective 5-year study in Moldova of acute renal failure due to leptospirosis: 58 cases and a review of the literature,” Nephrol. Dial. Transplant., 2003, vol. 18, pp. 1128–1134.
J. Tappero, D. Ashford, and B. Perkins, “Leptospira Species (Leptospirosis),” In: Mandell G, Bennet JE, Dolin R, eds. Mandell, Douglas, and Bennet’s “Principles and Practice of Infectious Diseases,” 5th ed. Philadelphia: “Churchill Livingstone”, 2000, Vol. 2, Part III, Chapter 229, pp. 2495–2501.
R. Higgin, and G. Cousineau, “The pathogenisis of leptospirosis II. Jaundice in experimental leptospirosis in guinea pigs,” Can. J. Comp. Med., 1977, vol. 41, pp. 182–187.
I. Anisimova, and V. Matiash, “The pathomorphology and pathogenetic problems of liver involvement in icterohemorrhagic leptospirosis,” Lik Sprava, 1999, vol. 4, pp. 111–116.
P. Abgueguen, V. Delbos, J. Blanvillain, J. Chennebault, J. Cottin, S. Fanello, and E. Pichard, “Clinical aspects and prognostic factors of leptospirosis in adults. Retrospective study in France,” J. Infect., 2008, vol. 57, pp. 171–178.
M. Chang, C. Yang, J. Chen, Y. Ho, M. Pan, C. Lin, and D. Lin, “Disproportional exaggerated aspartate transaminase is a useful prognostic parameter in late leptospirosis,” World J. Gastroenterol., 2005, vol. 11, pp. 5553–5556.
E. Maroun, E. Kushawaha, E. El-Charabaty, N. Mobarakai, and S. El-Sayegh, “Fulminant leptospirosis (Weil’s disease) in an urban setting as an overlooked cause of multiorgan failure: a case report,” J. Med. Case Reports, 2011, vol. 5, p. 7.
J. Wagenaar, M. Goris, D. Partiningrum, B. Isbandrio, R. Hartskeerl, D. Brandjes, J. Meijers, M. Gasem, and E. Van Gorp, “Coagulation disorders in patients with severe leptospirosis are associated with severe bleeding and mortality,” Trop. Med. Int. Health, 2010, vol. 15, pp. 152–159.
I. Asauljuk, O. Stanislavski, and N. Bubnov, “Hemosorbtion in complex treatment of cases with leptospirosis in phase of acute renal and liver failure,” Clin. Med., 1985, vol. 63(4), p. 114. Russian
D. Kaul, S. Flanders, and S. Saint, “Clear as mud,” N. Engl. J. Med., 2005, vol. 352, pp. 1914–1918.
T. Panaphut, S. Domrongkitchaiporn, and B. Thinkamrop, “Prognostic factors of death in leptospirosis: a prospective cohort study in Khon Kaen, Thailand,” Intern. J. of Inf. Dis., 2002, vol. 6(1), pp. 52–59.
A. Ko, M. Reis, C. Dourado, W. Johnson, L. Riley, and the Salvador Leptospirosis Study Group, “Urban epidemic of severe leptospirosis in Brazil,” Lancet, 1999, vol. 354 (9181), pp. 820–825.